New England Research & Management, Inc. Jazz Pharmaceuticals PLC Transaction History
New England Research & Management, Inc.
- $197 Million
- Q1 2025
A detailed history of New England Research & Management, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, New England Research & Management, Inc. holds 5,050 shares of JAZZ stock, worth $590,648. This represents 0.32% of its overall portfolio holdings.
Number of Shares
5,050Holding current value
$590,648% of portfolio
0.32%Shares
1 transactions
Others Institutions Holding JAZZ
# of Institutions
552Shares Held
59.8MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$719 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$706 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$296 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$259 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$238 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.33B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...